Surgery, Gastroenterology and Oncology
Vol. 28, No. 2, Jun 2023
Laparoscopic Ovarian Transposition for Young Patients with Locally Advanced Cervical Cancer Treated by Primary Chemoradiation: A Step-by-Step Surgical Technique Video
Stoyan Kostov, Yavor Kornovski, Yonka Ivanova, Stanislav Slavchev, Angel Yordanov
Video Case Report, Jun 2023
Article DOI: 10.21614/sgo-v.28-a.583


Cervical cancer is the fourth most common gynecological malignancy. It is a major health problem commonly affecting women in a young age. It is well known that the majority of cervical cancer cases are related to human papilloma virus. Therefore, in Europe the rate of cervical cancer is expected to decrease due to human papilloma virus vaccination (1-3). However, the discrepancy in cervical cancer cases is clearly seen between Eastern and Western European countries. Moreover, the estimated age-standardized incidence rate of cervical cancer is the highest in Bulgaria among all European countries (1-3). Surgery is the standard treatment therapy in early stages, whereas concurrent pelvic radiotherapy combined with chemotherapy is the preferable treatment modality in advanced cases (4). Annual cases of Bulgaria are one of the highest in Europe. The five-year relative overall survival for women with cervical cancer remains unacceptable low in Bulgaria. The reasons for this epidemiology crisis are due to the low vaccination rate (less than 6% for the first dose) and lack of population-based screening program. Approximately, one fifth of the patients are diagnosed between the age of 35 and 44 year. The incidence of patients diagnosed at advanced stage of the disease is expecting to high (1-3). Ovarian transposition could be an option for inoperable patients with advanced cervical cancer, which are referred to definitive chemoradiation. Ovarian transposition will probably prevent menopausal induced osteoporosis, cardiovascular morbidity and vaginal atrophy. Additionally, OT is an alternative method for patient with advanced cervical cancer desiring pregnancy. Herein, we described step by step laparoscopic ovarian transposition in cases of advanced cervical cancer. Patient selection criteria, surgical considerations during the procedure and postoperative complications are also highlighted in detail (5). Laparoscopic ovarian transposition is superior to the laparotomy, as it has fast recovery rate and reduced hospital stay. Therefore, the definitive treatment will not be delayed. Although ovarian transposition is not a curative procedure, it could improve the quality of life of patients with advanced cervical cancer referred to definitive chemoradiation.

 

 

Conflict of interest

All authors declare no conflict of interest .

 

Funding

No funding sources.

 

Ethical statement

The patient signed the inform concern.

 

References

1. Cancer Tomorrow. ((accessed on 1 April 2022)). Available online: https://gco.iarc.fr/tomorrow/en/dataviz/isotype?types=0&sexes=0&mode=population&group_populations=1&multiple_populations=1&multiple_cancers=0&cancers=23&populations=908&single_unit=5000

2. Bulgaria Source: Globocan Incidence, Mortality and Prevalence by Cancer Site. ((accessed on 1 December 2022)). Available online: https://gco.iarc.fr/today/data/factsheets/populations/100-bulgaria-fact-sheets.pdf

3. Yordanov A, Vasileva-Slaveva M, Galai N, Faraggi D, Kubelac MP, Tripac-Iacovleva I, et al. Cancer of the Cervix in Bulgaria: Epidemiology of a Crisis. Healthcare (Basel). 2023;11(3):318.

4. Cibula D, Raspollini MR, Planchamp F, Centeno C, Chargari C, Felix A, et al. ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023. Int J Gynecol Cancer. 2023;33(5):649-666.

5. Laios A, Duarte Portela S, Papadopoulou A, Gallos ID, Otify M, Ind T. Ovarian transposition and cervical cancer. Best Pract Res Clin Obstet Gynaecol. 2021;75:37-53.



Full Text Sources: Download pdf
Abstract:   Abstract EN
Views: 419


Watch Video Articles


For Authors



Journal Subscriptions

Current Issue

Mar 2024

Supplements

Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)

e-ISSN: 2601 - 1700 (online)

ISSN-L: 2559 - 723X

Journal Abbreviation: Surg. Gastroenterol. Oncol.

Surgery, Gastroenterology and Oncology (SGO) is indexed in:
  • SCOPUS
  • EBSCO
  • DOI/Crossref
  • Google Scholar
  • SCImago
  • Harvard Library
  • Open Academic Journals Index (OAJI)

Open Access Statement

Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.

Journal Metrics

Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2



Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019

Creative Commons License
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/